Home

Neil Kumar

CIK 1742485 · Chief Executive Officer · last filed 2026-06-18

Neil Kumar is a Chief Executive Officer who has filed 103 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for BBOT, was dated Jun 18, 2026. Across all open-market trades the lifetime net is −$73.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $392.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$391.97M

Companies

3

Total Filings

103

Lifetime Open-Market Net

-$73.07M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BBOT Director — $8.59 — $0 1 2026-06-18
BBIO Chief Executive Officer 4,581,774 $85.55 $391.97M -$145.07M 76 2026-06-08
Eidos Therapeutics, Inc. (EIDX) Delisted Chief Executive Officer 24,575,501 — — $72.01M 3 2019-07-08

Recent Filings

103 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-18 BBOT Grant (A) — $0 EDGAR
2026-06-08 BBIO Sell (S) −80,000 -$5.41M EDGAR
2026-05-26 BBIO Sell (S) −26,103 -$1.81M EDGAR
2026-05-21 BBIO Notice (144) −26,103 -$1.78M EDGAR
2026-05-19 BBIO Mixed +34,979 -$2.40M EDGAR
2026-05-11 BBIO Sell (S) −80,000 -$5.39M EDGAR
2026-04-13 BBIO Sell (S) −80,000 -$5.97M EDGAR
2026-04-09 BBIO Notice (144) −120,000 -$8.90M EDGAR
2026-03-19 BBIO Grant (A) — $0 EDGAR
2026-03-16 BBIO Sell (S) −80,000 -$5.50M EDGAR
Showing 1–10 of 103
Page 1 of 11
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.